Agoracom Blog Home

Archive for the ‘AGORACOM Client Feature’ Category

Bougainville Ventures Inc $BOG.ca – Nearly 1 in 6 Canadians Have Used Marijuana Since Recreational Pot Was Legalized $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 12:33 PM on Monday, February 25th, 2019
SPONSOR:  Bougainville Ventures Inc (CSE: BOG) Converting irrigated farmland to greenhouse-equipped farmland. Bougainville does not “touch the plant” and only provides agricultural infrastructure as a landlord for licensed marijuana growers. Click here for more info.
BOG:CSE
—————————————

Nearly 1 in 6 Canadians Have Used Marijuana Since Recreational Pot Was Legalized

New data from Statistics Canada offers an inside look at cannabis consumption rates based on province, gender, and age.

  • The sky seems to be the limit for the legal marijuana industry.
  • According to the most bullish forecast from Wall Street investment firm Cowen Group, the legal weed industry could surpass soda in global sales by 2030 and generate $75 billion in yearly revenue.
  • More immediately, a co-authored report from Arcview Market Research and BDS Analytics has called for 38% global sales growth in 2019 to $16.9 billion.

Sean Williams Feb 23, 2019 at 10:51AM

The sky seems to be the limit for the legal marijuana industry. According to the most bullish forecast from Wall Street investment firm Cowen Group, the legal weed industry could surpass soda in global sales by 2030 and generate $75 billion in yearly revenue. More immediately, a co-authored report from Arcview Market Research and BDS Analytics has called for 38% global sales growth in 2019 to $16.9 billion. No matter how you analyze the data, that’s a lot of green to go around; and it’s a big reason why pot stocks have been virtually unstoppable since the year began.

Although the United States would represent the largest cannabis market in the world by sales if it were legalized at the federal level, it’s our northerly neighbor Canada that’s leading the charge on marijuana reform. Having become the first industrialized country in the world, and only second overall behind Uruguay, to legalize adult-use pot in October, Canada looks to be on track for an estimated $5.9 billion in annual sales by 2022.

Image source: Getty Images.

An inside look at the average Canadian cannabis user

But just how quickly are Canadians adapting to this legalized environment? For that answer, I turn to Statistics Canada, the national statistics office that gathers information on Canada’s economy, environment, and society.

Recently (as of Feb. 21, 2019), Statistics Canada released self-reported data on consumers’ use of cannabis over the past three months. As a refresher, marijuana legalization occurred roughly four months ago, although the first month was a supply-side disaster. That means the past three months of use should give us a really good idea of what the typical Canadian consumer looks like.

According to the data, which Statistics Canada will continue to update, 15.4% of all citizens, or nearly 1 out of 6 Canadians, have used cannabis over the past three months. As you can imagine, usage statistics tend to vary by region, gender, and age. For instance, Quebec had the lowest percentage of people using marijuana over the past three months (13.6%), while the lesser-populated Nova Scotia had the highest percentage by far at 21.6%. Newfoundland and Labrador and New Brunswick were also significantly above the national self-reported average in three-month use rates.

In terms of gender, men were significantly more likely than women (19.4% vs. 11.3%) to have consumed cannabis recently.

Finally, as you might expect, pot use over the past three months was considerably higher among younger people than older folks. Overall, 27.4% of Canadians aged 15 to 24 and 23.2% of those aged 25 to 34 used cannabis over the past three months. Meanwhile, just 5.2% of seniors aged 65 and up and 10.4% of Canadians aged 55 to 64 used weed recently. Even though the older generation has more disposable income, it’s these younger adults that are the future of the legal weed industry. 

Image source: Getty Images.

Cannabis consumption rates are likely to rise — here’s why

Although there were no major surprises here, there are some relatively interesting takeaways to be made.

For example, an average use rate of just 15.4% might seem rather low, but it’s not factoring in two pretty important catalysts. First, there’s the fact that marijuana growers are still in the early stages of ramping up their production. Aurora Cannabis (NYSE:ACB), which is my selection to lead the country with 700,000 kilograms of peak annual production, is only producing at an annual run rate of 120,000 kilos right now. By the end of the current calendar quarter, Aurora Cannabis should be yielding more than 150,000 kilos annually, but it’s going to take perhaps 12 to 24 more months before Aurora is operating on all cylinders. When consumers have access to ample demand and the per-gram price for dried cannabis flower comes down a bit, we’re liable to see usage rates increase.

The second catalyst is the expected legalization of new consumption options by this fall. When the Cannabis Act was signed into law last June, and legal product sales commenced on Oct. 17, 2018, it only included dried flower, cannabis oil, and sprays. Alternative products such as edibles and cannabis-infused beverages aren’t yet legal. That, however, is expected to change by no later than Oct. 17, 2019, according to an outline presented by Health Canada. Edibles and infused beverages containing cannabidiol (CBD), the nonpsychoactive cannabinoid best known for its medical benefits, are expected to be especially important in luring in new users.

The provincial-use data is also interesting in that it highlights one potential under-the-radar grower: OrganiGram Holdings (NASDAQOTH:OGRMF). The New Brunswick-based OrganiGram is the only Atlantic grower expected to yield more than 100,000 kilograms per year when at full production capacity. Its geographic location gives it competitive advantages in New Brunswick, Nova Scotia, and Newfoundland and Labrador. Sure, these are far less populated regions than, say, Ontario or Quebec, but it nevertheless allows OrganiGram a foothold in these potentially higher-use provinces and territories. OrganiGram was already a value stock among its peers, but it’s now that much more intriguing following the release of this data.

Image source: Getty Images.

I believe this data also demonstrates the scope of opportunity awaiting Shopify (NYSE:SHOP) and its e-commerce platform. A number of large growers and provinces, including Ontario, have chosen to utilize Shopify’s sales platform for online and brick-and-mortar sales. Aside from simply being the sales platform of choice, Shopify offers marijuana companies purchasing data on consumers for pretty much the first time ever. With this being a cash-dominated industry, it’s been virtually impossible for growers and retailers to understand their customer base. With Shopify, this is going to change, and both producers and retailers will be able to more directly target consumers.

Ultimately, the legal weed industry is still in its infancy in Canada. That means we’re liable to see this data shift as Health Canada adjusts the boundaries of what’s legal and growers and retailers come to better understand their customers.

Source: https://www.fool.com/investing/2019/02/23/nearly-1-in-6-canadians-have-used-marijuana-since.aspx

CLIENT FEATURE: Star Navigation $SNA.ca Real-Time Flight Tracking and Monitoring Technology

Posted by AGORACOM-JC at 11:53 AM on Monday, February 25th, 2019

RECENT HIGHLIGHTS

SIGNED A COOPERATION AGREEMENT FOR THE EMERGENCY MEDICAL SERVICES MARKETS

  • Will enable them to provide real-time monitoring of patients while in transit on the ground or in the air.
  • CHUSJ is one of the top 10 mother-child hospitals in the World, with over 3500 births a year.
  • Has over 1500 nurses, over 500 Doctors and over 200 researchers on staff.

COMPLETED SALE OF FIVE STAR-A.D.S SYSTEMS TO ALMASRIA UNIVERSAL AIRLINES

  • Announced that AlMasria Universal Airlines of Egypt has decided to proceed with the installation and activation of the STAR-A.D.S.® System across all five (5) of its current aircraft fleet, which includes A-320, A-321, A330 and B737 aircraft.

BOMBARDER JOINT RESEARCH AND DEVELOPMENT PROGRAM

  • Joint research and development program with Bombardier and other industrials and universities of Canada is progressing very positively.
  • The STAR-A.D.S. ® system which is at the heart of the program, after having been validated and extensively used by the aircraft manufacturer, has now been transferred to another flight test vehicle to complete the flight testing and the data collection.

EMERGENCY MEDICAL SERVICES APPLICATIONS

  • Star’s Land System Aided Medical Monitoring system for ground ambulance applications has undergone a series of demonstrations by a care organization in North America.
  • Its airborne parent system, the In-Flight System Aided Medical Monitoring system (STAR-ISAMM™â€), has now been demonstrated to several stakeholders of the commercial and civil air ambulance market.

CHECK OUT OUR RECENT INTERVIEW

FULL DISCLOSURE: Star Navigation Systems Group Ltd. is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: Tartisan Nickel $TN.ca Kenbridge Property Hosts M&I Resource of 7.14 Million Tonnes at 0.62% Nickel, 0.33% Copper $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 11:25 AM on Thursday, February 21st, 2019

Investment Highlights

  • Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
  • 17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property

Kenbridge Ni Project (ON, Canada)

  • Advanced  stage  deposit  remains open  in  three  directions,  is  equipped with a 623m  deep  shaft  and  has  never  been  mined. 
  • Preliminary  Economic Assessment completed and updated returned robust project 
    economics and operating costs including  a  NPV  of  C$253M  and  cash costs of US$3.47/lb of nickel net of  
    copper credits.
  • Plans for Kenbridge include updating PEA, advancing the project through to feasibility and exploring the open mineralization at depth

FULL DISCLOSURE: Tartisan Nickel Corp. is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: CardioComm Solutions $EKG.ca – The heartbeat of Cardiovascular Medicine and Telemedicine

Posted by AGORACOM-JC at 5:02 PM on Thursday, February 14th, 2019

Global Leaders in Mobile  ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Recent Highlights

CardioComm Solutions’ HeartCheck(TM) Device Enters Final FDA Review Phase Read More

  • Completed a request for additional information from the US Food and Drug Administration (“FDA”) for the Company’s premarket notification 510(k), Class II medical device clearance application for the HeartCheck™ CardiBeat and GEMS™ Mobile Application.
  • Company had submitted a letter of revocation of their supplementary information submission on December 26, 2018 in compliance with the FDA’s directive

CardioComm Solutions’ HeartCheck(TM) CardiBeat and Smart Phone App Enter Final Stage of FDA 510(k) Review Read More

  • Market Release of HeartCheck(TM) CardiBeat and GEMS(TM) Mobile Application Set For Early 2019
  • Completed its response to the USA Food and Drug Administration for additional information following the Company’s filing of its premarket notification 510(k)
    • Class II medical device clearance application for the HeartCheck™ CardiBeat and GEMS™ Mobile Application
  • HeartCheck™ CardiBeat is the second of several planned Bluetooth-enabled ECG recording devices to be marketed by the Company

Launched 12-Lead ECG Smart Wearable Garment Monitoring Solution Read More

  • Announced joint partnership sales plans for the commercial launch of its newest software release designed to support an innovative and easy to use wireless, 12 lead ECG, vital signs, arrhythmia and ischemia monitoring wearable smart garment manufactured by Israel-based HealthWatch Technologies Ltd.

Products

The Project: Arrhythmia Screening and Medical Adherence

An Innovator in the Mobile ECG Industry

Company Accolades

 FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: North Bud Farms $NBUD.ca sustainable low cost, high quality cannabinoid production and procurement $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 11:40 AM on Thursday, February 14th, 2019

WHY NORTHBUD FARMS?

  • Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year
    As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
  • Infused products sector has become the highest margin segment of the industry
  • Positioned to be a raw input producer for this space
  • Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products
  • Announced Creation of “1017” Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line

THE OPPORTUNITY

  • Acquired late stage ACMPR applicant GrowPros MMP from Tetra Bio-Pharma (TSXV: TBP)
  • GrowPros MMP application was submitted in November 2014 and is currently in the ‘Confirmation of Readiness’ stage.
  • Announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area
  • Phase 1 is located on 95 acres of agricultural farmland in Low, Québec.
  • Option exists to acquire more land if needed
  • Facility will focus on GMP (higher production grade) pharma-grade cultivation and food-grade extracted inputs

CHECK OUT OUR RECENT INTERVIEW

FULL DISCLOSURE: North Bud Farms is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: Tartisan Nickel $TN.ca Kenbridge Property Hosts M&I Resource of 7.14 Million Tonnes at 0.62% Nickel, 0.33% Copper

Posted by AGORACOM-JC at 11:17 AM on Tuesday, February 12th, 2019

Investment Highlights

  • Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
  • 17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property

Kenbridge Ni Project (ON, Canada)

  • Advanced  stage  deposit  remains open  in  three  directions,  is  equipped with a 623m  deep  shaft  and  has  never  been  mined. 
  • Preliminary  Economic Assessment completed and updated returned robust project 
    economics and operating costs including  a  NPV  of  C$253M  and  cash costs of US$3.47/lb of nickel net of  
    copper credits.
  • Plans for Kenbridge include updating PEA, advancing the project through to feasibility and exploring the open mineralization at depth

FULL DISCLOSURE: Tartisan Nickel Corp. is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: CardioComm Solutions $EKG.ca – The heartbeat of Cardiovascular Medicine and Telemedicine

Posted by AGORACOM-JC at 3:54 PM on Wednesday, February 6th, 2019
Logo large

The heartbeat of cardiovascular medicine and telemedicine

  • Specializing in the software engineering of computer based electrocardiogram (heart monitoring) management and reporting software
  • Software permits physician interpretations of ECGs and supports private and public payer fee-for-service billings
  • ECGs are electrical recordings of the heart and performing an ECG is one of the most common diagnostic tests performed
  • Successfully launched technologies that enable the use of new medical devices and communication portals utilizing internet and cellular based technologies for the recording, transmission and viewing of ECGs

Recent Highlights

CardioComm Solutions’ HeartCheck(TM) Device Enters Final FDA Review Phase Read More

  • Completed a request for additional information from the US Food and Drug Administration (“FDA”) for the Company’s premarket notification 510(k), Class II medical device clearance application for the HeartCheck™ CardiBeat and GEMS™ Mobile Application.
  • Company had submitted a letter of revocation of their supplementary information submission on December 26, 2018 in compliance with the FDA’s directive

CardioComm Solutions’ HeartCheck(TM) CardiBeat and Smart Phone App Enter Final Stage of FDA 510(k) Review Read More

  • Market Release of HeartCheck(TM) CardiBeat and GEMS(TM) Mobile Application Set For Early 2019
  • Completed its response to the USA Food and Drug Administration for additional information following the Company’s filing of its premarket notification 510(k)
    • Class II medical device clearance application for the HeartCheck™ CardiBeat and GEMS™ Mobile Application
  • HeartCheck™ CardiBeat is the second of several planned Bluetooth-enabled ECG recording devices to be marketed by the Company

Launched 12-Lead ECG Smart Wearable Garment Monitoring Solution Read More

  • Announced joint partnership sales plans for the commercial launch of its newest software release designed to support an innovative and easy to use wireless, 12 lead ECG, vital signs, arrhythmia and ischemia monitoring wearable smart garment manufactured by Israel-based HealthWatch Technologies Ltd.

Company to Receive Royalty Payments from Biotricity Read More

  • Confirmed progress on a royalty licencing agreement with Biotricty Inc.
  • Royalty payment phase became active following confirmation that all necessary clearance and software development pre-conditions have been achieved
  • Royalty fees are due from the use of the ECG software Cardiocomm developed, or any derivative products, on a per patient monitored basis

First Company to Receive Approval for ECG Product Sales Direct to Consumers Read More

  • CardioComm was the first company to be approved to sell an ECG product directly to consumers in North America as evidenced by OTC Class II medical device clearances by both the United States Food and Drug Adminstration and Health Canada in 2012
  • HeartCheck ECG PEN is currently available for OTC sales on the shelves of Canadian pharmacy chain Shoppers Drug Mart.

Completed HeartCheck(TM) Clinical Validation for Long-Term, Self-Managed, Remote Monitoring of Atrial Fibrillation Patients Post-Ablation Read More

  • Moved into routine clinical use following completion of a long-term, remote arrhythmia monitoring pilot in high risk patients.
  • PACE cardiologists have been prescribing use of the HeartCheck™ ECG PEN and ECG Handheld Monitor to their patients to provide up to one year of enhanced remote patient monitoring for arrhythmias in addition to use of conventional but term-limited Holter and event monitoring.

Products

HeartCheck™ Pen

The HeartCheck™ PEN handheld ECG device is the only device of its kind cleared by the FDA for consumer use.


✓ Monitor For Arrhythmias Anywhere
✓ Web Access to a Qualified Physician
✓ No Prescription Required

 
The pocket-sized PEN allows you to take heart readings from anywhere, the moment symptoms appear.

The HeartCheck™ ECG Device

The FDA-cleared HeartCheck™ ECG device is portable, easy to use and can store up to 200 thirty second ECG readings.

Whether at home, the gym or at the office, the HeartCheck™ ECG Device with SMART Monitoring can help detect and monitor arrhythmias from wherever you are.  

  Features & Benefits
✓ SMART Monitoring ECG Interpretations
✓ Cleared by the Food and Drug Administration (FDA)
✓ Easy to use
✓ Accurate heart readings in only 30 seconds
✓ Store up to 200 ECGs

Company Accolades


FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: Tartisan Nickel $TN.ca Kenbridge Property Hosts M&I Resource of 7.14 Million Tonnes at 0.62% Nickel, 0.33% Copper $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 11:09 AM on Tuesday, February 5th, 2019

Investment Highlights

  • Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
  • 17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property

Kenbridge Ni Project (ON, Canada)

  • Advanced  stage  deposit  remains open  in  three  directions,  is  equipped with a 623m  deep  shaft  and  has  never  been  mined. 
  • Preliminary  Economic Assessment completed and updated returned robust project 
    economics and operating costs including  a  NPV  of  C$253M  and  cash costs of US$3.47/lb of nickel net of  
    copper credits.
  • Plans for Kenbridge include updating PEA, advancing the project through to feasibility and exploring the open mineralization at depth

FULL DISCLOSURE: Tartisan Nickel Corp. is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: Tartisan Nickel $TN.ca Kenbridge Property Hosts M&I Resource of 7.14 Million Tonnes at 0.62% Nickel, 0.33% Copper $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 11:46 AM on Thursday, January 31st, 2019

Investment Highlights

  • Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
  • 17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property

Kenbridge Ni Project (ON, Canada)

  • Advanced  stage  deposit  remains open  in  three  directions,  is  equipped with a 623m  deep  shaft  and  has  never  been  mined. 
  • Preliminary  Economic Assessment completed and updated returned robust project 
    economics and operating costs including  a  NPV  of  C$253M  and  cash costs of US$3.47/lb of nickel net of  
    copper credits.
  • Plans for Kenbridge include updating PEA, advancing the project through to feasibility and exploring the open mineralization at depth

FULL DISCLOSURE: Tartisan Nickel Corp. is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: North Bud Farms $NBUD.ca sustainable low cost, high quality cannabinoid production and procurement

Posted by AGORACOM-JC at 3:51 PM on Wednesday, January 30th, 2019

WHY NORTHBUD FARMS?

  • Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year
    As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
  • Infused products sector has become the highest margin segment of the industry
  • Positioned to be a raw input producer for this space
  • Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products
  • Announced Creation of “1017” Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line

THE OPPORTUNITY

  • Acquired late stage ACMPR applicant GrowPros MMP from Tetra Bio-Pharma (TSXV: TBP)
  • GrowPros MMP application was submitted in November 2014 and is currently in the ‘Confirmation of Readiness’ stage.
  • Announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area
  • Phase 1 is located on 95 acres of agricultural farmland in Low, Québec.
  • Option exists to acquire more land if needed
  • Facility will focus on GMP (higher production grade) pharma-grade cultivation and food-grade extracted inputs

FULL DISCLOSURE: North Bud Farms is an advertising client of AGORA Internet Relations Corp.